330 related articles for article (PubMed ID: 28091594)
41. An RRM-ZnF RNA recognition module targets RBM10 to exonic sequences to promote exon exclusion.
Collins KM; Kainov YA; Christodolou E; Ray D; Morris Q; Hughes T; Taylor IA; Makeyev EV; Ramos A
Nucleic Acids Res; 2017 Jun; 45(11):6761-6774. PubMed ID: 28379442
[TBL] [Abstract][Full Text] [Related]
42. Limb-Bud and Heart Attenuates Growth and Invasion of Human Lung Adenocarcinoma Cells and Predicts Survival Outcome.
Deng M; Yu R; Wang S; Zhang Y; Li Z; Song H; Liu B; Xu L; Wang X; Zhang Z; Lv Q; Wang X; Che X; Qu X; Liu Y; Hu X
Cell Physiol Biochem; 2018; 47(1):223-234. PubMed ID: 29788015
[TBL] [Abstract][Full Text] [Related]
43. Function of low ADARB1 expression in lung adenocarcinoma.
Wang X; Xu Z; Ren X; Chen X; Wei J; Lin W; Li Z; Ou C; Gong Z; Yan Y
PLoS One; 2019; 14(9):e0222298. PubMed ID: 31491024
[TBL] [Abstract][Full Text] [Related]
44. Identification of alternative splicing events regulated by the oncogenic factor SRSF1 in lung cancer.
de Miguel FJ; Sharma RD; Pajares MJ; Montuenga LM; Rubio A; Pio R
Cancer Res; 2014 Feb; 74(4):1105-15. PubMed ID: 24371231
[TBL] [Abstract][Full Text] [Related]
45. A gene mutation in RNA-binding protein 10 is associated with lung adenocarcinoma progression and poor prognosis.
Yin LL; Wen XM; Li M; Xu YM; Zhao XF; Li J; Wang XW
Oncol Lett; 2018 Nov; 16(5):6283-6292. PubMed ID: 30405763
[TBL] [Abstract][Full Text] [Related]
46. The splicing factor SRSF6 is amplified and is an oncoprotein in lung and colon cancers.
Cohen-Eliav M; Golan-Gerstl R; Siegfried Z; Andersen CL; Thorsen K; Ørntoft TF; Mu D; Karni R
J Pathol; 2013 Mar; 229(4):630-9. PubMed ID: 23132731
[TBL] [Abstract][Full Text] [Related]
47. RBM10 C761Y mutation induced oncogenic ASPM isoforms and regulated β-catenin signaling in cholangiocarcinoma.
Chang J; Zhang Y; Zhou T; Qiao Q; Shan J; Chen Y; Jiang W; Wang Y; Liu S; Wang Y; Yu Y; Li C; Li X
J Exp Clin Cancer Res; 2024 Apr; 43(1):104. PubMed ID: 38576051
[TBL] [Abstract][Full Text] [Related]
48. A pan-cancer analysis of transcriptome changes associated with somatic mutations in U2AF1 reveals commonly altered splicing events.
Brooks AN; Choi PS; de Waal L; Sharifnia T; Imielinski M; Saksena G; Pedamallu CS; Sivachenko A; Rosenberg M; Chmielecki J; Lawrence MS; DeLuca DS; Getz G; Meyerson M
PLoS One; 2014; 9(1):e87361. PubMed ID: 24498085
[TBL] [Abstract][Full Text] [Related]
49. Low expression of LINC00982 and PRDM16 is associated with altered gene expression, damaged pathways and poor survival in lung adenocarcinoma.
Lv W; Yu X; Li W; Feng N; Feng T; Wang Y; Lin H; Qian B
Oncol Rep; 2018 Nov; 40(5):2698-2709. PubMed ID: 30132554
[TBL] [Abstract][Full Text] [Related]
50. Splicing Site Recognition by Synergy of Three Domains in Splicing Factor RBM10.
Serrano P; Hammond JA; Geralt M; Wüthrich K
Biochemistry; 2018 Mar; 57(10):1563-1567. PubMed ID: 29450990
[TBL] [Abstract][Full Text] [Related]
51. RBM5, 6, and 10 differentially regulate NUMB alternative splicing to control cancer cell proliferation.
Bechara EG; Sebestyén E; Bernardis I; Eyras E; Valcárcel J
Mol Cell; 2013 Dec; 52(5):720-33. PubMed ID: 24332178
[TBL] [Abstract][Full Text] [Related]
52. The RNA-binding protein QKI suppresses cancer-associated aberrant splicing.
Zong FY; Fu X; Wei WJ; Luo YG; Heiner M; Cao LJ; Fang Z; Fang R; Lu D; Ji H; Hui J
PLoS Genet; 2014 Apr; 10(4):e1004289. PubMed ID: 24722255
[TBL] [Abstract][Full Text] [Related]
53. DDX17 modulates the expression and alternative splicing of genes involved in apoptosis and proliferation in lung adenocarcinoma cells.
He C; Zhang G; Lu Y; Zhou J; Ren Z
PeerJ; 2022; 10():e13895. PubMed ID: 36164607
[TBL] [Abstract][Full Text] [Related]
54. Genome-wide isoform-level analysis reveals tumor-specific isoforms for lung adenocarcinoma diagnosis and prognosis.
Zhuhong H; Zhenyu B; Xiangyuan C; Tingzhen X; Libin S
Cancer Genet; 2019 Jan; 230():58-65. PubMed ID: 30470588
[TBL] [Abstract][Full Text] [Related]
55. RBM10 promotes transformation-associated processes in small cell lung cancer and is directly regulated by RBM5.
Loiselle JJ; Roy JG; Sutherland LC
PLoS One; 2017; 12(6):e0180258. PubMed ID: 28662214
[TBL] [Abstract][Full Text] [Related]
56. RBM10: Harmful or helpful-many factors to consider.
Loiselle JJ; Sutherland LC
J Cell Biochem; 2018 May; 119(5):3809-3818. PubMed ID: 29274279
[TBL] [Abstract][Full Text] [Related]
57. Association of specific gene mutations derived from machine learning with survival in lung adenocarcinoma.
Cho HJ; Lee S; Ji YG; Lee DH
PLoS One; 2018; 13(11):e0207204. PubMed ID: 30419062
[TBL] [Abstract][Full Text] [Related]
58. Triple-layer dissection of the lung adenocarcinoma transcriptome: regulation at the gene, transcript, and exon levels.
Hsu MK; Wu IC; Cheng CC; Su JL; Hsieh CH; Lin YS; Chen FC
Oncotarget; 2015 Oct; 6(30):28755-73. PubMed ID: 26356813
[TBL] [Abstract][Full Text] [Related]
59. QKI-5 regulates the alternative splicing of cytoskeletal gene ADD3 in lung cancer.
Wang JZ; Fu X; Fang Z; Liu H; Zong FY; Zhu H; Yu YF; Zhang XY; Wang SF; Huang Y; Hui J
J Mol Cell Biol; 2021 Aug; 13(5):347-360. PubMed ID: 33196842
[TBL] [Abstract][Full Text] [Related]
60. Somatic A-to-I RNA-edited RHOA isoform 2 specific-R176G mutation promotes tumor progression in lung adenocarcinoma.
Chen KJ; Huang JH; Shih JH; Gu DL; Lee SS; Shen R; Hsu YH; Kung YC; Wu CY; Ho CM; Jen HW; Lee HY; Lang YD; Hsiao CH; Jou YS
Mol Carcinog; 2023 Mar; 62(3):348-359. PubMed ID: 36453714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
